Although endothelial cell damage is an established pathological mechanism in diabetes, and despite ongoing clinical studies on the use of NADPH oxidase inhibitors [97], there are no effective drugs for endothelial cell protection that have been adopted in this disease. The gene discussed is FMO5; the disease is diabetes mellitus.